Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax
about
Antitoxin Treatment of Inhalation Anthrax: A Systematic ReviewEfficacy Projection of Obiltoxaximab for Treatment of Inhalational Anthrax across a Range of Disease SeverityAn overview of investigational toxin-directed therapies for the adjunctive management of Bacillus anthracis infection and sepsis.Obiltoxaximab: Adding to the Treatment Arsenal for Bacillus anthracis Infection.Obiltoxaximab: First Global Approval.Anthrax immune globulin improves hemodynamics and survival during B. anthracis toxin-induced shock in canines receiving titrated fluid and vasopressor support.
P2860
Efficacy of ETI-204 monoclonal antibody as an adjunct therapy in a New Zealand white rabbit partial survival model for inhalational anthrax
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@ast
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@en
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@nl
type
label
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@ast
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@en
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@nl
prefLabel
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@ast
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@en
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@nl
P2093
P2860
P921
P3181
P356
P1476
Efficacy of ETI-204 monoclonal ...... model for inhalational anthrax
@en
P2093
David Dyer
Katie Beck
Marc Mattix
Nancy Twenhafel
P2860
P304
P3181
P356
10.1128/AAC.04593-14
P407
P577
2015-02-02T00:00:00Z